omniture

WuXiPharmaTech Fills Two Key Leadership Positions with Internal Candidates

2007-01-25 11:26 2082

SHANGHAI, China, Jan. 25 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it has promoted Dr. Suhan Tang and Dr. Hai Mi to Chief Manufacturing Officer and Vice President of Corporate Communications respectively.

(Logo: http://www.prnasia.com:9080/sa/200611271812.jpg )

Dr. Suhan Tang joined the company in 2003 as Vice President of Process R&D, from Schering-Plough (NYSE: SGP), New Jersey, US. Over the last three years, he has been instrumental in shaping and developing the process chemistry and scale-up manufacturing service offerings. Under his leadership, SynTheAll Pharmaceutical, the wholly owned subsidiary of WuXi PharmaTech, has successfully passed a number of client audits and won many supplier awards. As a result, SynTheAll has seen an increasing number of long-term collaboration agreements with many well-known pharmaceutical companies.

As a former business consultant and scientist for Pfizer (NYSE: PFE), Dr. Hai Mi joined the company two years ago as the Senior Director of Strategic Planning. In this role he provided guidance on numerous executive decisions and oversaw the Public Relations Department. His promotion reflects the importance of enhanced communication with all of WuXi PharmaTech's internal and external partners.

Both Suhan Tang and Hai Mi will report directly to Dr. Ge Li, Chairman and CEO of the company.

"We are very happy to have two well-qualified internal candidates to fill the two very important executive posts. Both Suhan and Hai are proven leaders who have a strong commitment to WuXi PharmaTech," commented Dr. Li, "I am confident that both of them will continue to build on the company's strengths, as well as effectively provide leadership for new directions in their respective functional areas."

About WuXi PharmaTech Co. Ltd

Founded in 2001, Shanghai-based WuXi PharmaTech is China's leading drug R&D service company. As a research-driven and customer-focused company, WuXi PharmaTech offers global pharmaceutical and biopharmaceutical companies a diverse, value-added, and fully integrated portfolio of outsourcing services ranging from discovery chemistry, and process chemistry to service biology, bioanalytical chemistry, and large scale GMP manufacturing. WuXi PharmaTech assists its global partners in shorting the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save our clients both time and money. Currently, our client list consists of 19 of the top 20 pharmaceutical, and 8 of the top 10 biopharmaceutical companies. For more information, please visit: http://www.pharmatechs.com .

For more information, please contact:

Sherry Shao

Tel: +86-21-50464002

Email: PR@pharmatechs.com

Source: WuXi PharmaTech., Ltd.
collection